These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2141051)
1. [Chemotherapy with fluoropyrimidines for MOPC-104E plasmacytoma transplanted in mice with CCl4 induced chronic liver dysfunction]. Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Tobe T Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):640-7. PubMed ID: 2141051 [TBL] [Abstract][Full Text] [Related]
2. Low uracil concentration in the liver might be responsible for the decreased antineoplastic activity of fluoropyrimidines in mice with CCl4-induced chronic liver dysfunction. Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Kawabata K; Fukumoto M; Tobe T Oncology; 1991; 48(3):246-52. PubMed ID: 2023705 [TBL] [Abstract][Full Text] [Related]
3. Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracil. Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Imai S; Tobe T Anticancer Res; 1991; 11(2):607-12. PubMed ID: 2064315 [TBL] [Abstract][Full Text] [Related]
4. [Effect of fluoropyrimidine, drugs of tegafur and UFT on transplanted tumor in liver-damaged mice]. Aoike A; Hosokawa T; Koyama K; Rokutan K; Nishi Y; Yoshida A; Nakamura K; Kawai K Gan To Kagaku Ryoho; 1988 Oct; 15(10):2899-905. PubMed ID: 3140731 [TBL] [Abstract][Full Text] [Related]
5. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine. Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974 [TBL] [Abstract][Full Text] [Related]
6. [Anti-tumor effect of fluoropyrimidines on human tumor cell lines transplanted in nude mice with CCl4-induced liver dysfunction]. Nio Y; Imai S; Shiraishi T; Ohgaki K; Tobe T Nihon Geka Gakkai Zasshi; 1989 Apr; 90(4):538-45. PubMed ID: 2503704 [TBL] [Abstract][Full Text] [Related]
7. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Yonekura K; Basaki Y; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Wierzba K; Yamada Y Clin Cancer Res; 1999 Aug; 5(8):2185-91. PubMed ID: 10473104 [TBL] [Abstract][Full Text] [Related]
8. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study]. Nakashima T; Miyagi M; Kusumoto T Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316 [TBL] [Abstract][Full Text] [Related]
9. Randomized Controlled Trial of Adjuvant Chemotherapy with Fluoropyrimidines Moon JH; Fujiwara Y; Hirao M; Imamura H; Kimura Y; Fujitani K; Fujita J; Tamura S; Takiguchi S; Yano M; Mori M; Doki Y Anticancer Res; 2017 Jun; 37(6):3061-3067. PubMed ID: 28551645 [TBL] [Abstract][Full Text] [Related]
10. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors]. Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay. Anai H; Maehara Y; Kusumoto H; Kusumoto T; Sugimachi K Oncology; 1988; 45(3):144-7. PubMed ID: 3130595 [TBL] [Abstract][Full Text] [Related]
12. [Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)]. Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kato K Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):422-8. PubMed ID: 3131462 [TBL] [Abstract][Full Text] [Related]
13. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface. Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756 [TBL] [Abstract][Full Text] [Related]
14. UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil. Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K Chemotherapy; 1988; 34(6):484-9. PubMed ID: 3149571 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of fluoropyrimidines]. Fujita H Gan To Kagaku Ryoho; 1984 Nov; 11(11):2307-15. PubMed ID: 6437341 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur. Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats]. Kuwata K; Nagayama S; Hirakawa Y; Matsushima E; Kawaguchi Y Gan To Kagaku Ryoho; 2000 Jun; 27(6):885-90. PubMed ID: 10897216 [TBL] [Abstract][Full Text] [Related]
18. [Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia]. Kato T; Ota K Gan To Kagaku Ryoho; 1987 Feb; 14(2):502-5. PubMed ID: 2949703 [TBL] [Abstract][Full Text] [Related]
19. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT]. Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507 [TBL] [Abstract][Full Text] [Related]
20. [Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues]. Yoshiya N; Adachi S; Misawa Y; Ishida M; Yuzawa H; Kanazawa K; Takeuchi S Gan To Kagaku Ryoho; 1988 Feb; 15(2):285-9. PubMed ID: 3124768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]